Results 321 to 330 of about 13,924,024 (337)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Drug-like Density: A Method of Quantifying the "Bindability" of a Protein Target Based on a Very Large Set of Pockets and Drug-like Ligands from the Protein Data Bank

Journal of Chemical Information and Modeling, 2010
Robert P. Sheridan, Vladimir N. Maiorov, M. Katharine Holloway, Wendy D. Cornell, Ying Gao   +4 more
semanticscholar   +1 more source

Recent Progress in the Management of Advanced Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2007
Brian I Rini
exaly  

Combinatorial microRNA target predictions

Nature Genetics, 2005
A. Krek, Dominic Grün, Matthew N. Poy, Rachel Z. Wolf, Lauren Rosenberg, E. J. Epstein, P. MacMenamin, I. Piedade, K. Gunsalus, M. Stoffel, N. Rajewsky   +10 more
semanticscholar   +1 more source

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015

Ca-A Cancer Journal for Clinicians, 2007
Carolyn D Runowicz
exaly  

Protein Targeting

2008
openaire   +1 more source

Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins

Nature, 2000
A. Lasorella, M. Noseda, Mercedes Beyna, A. Iavarone   +3 more
semanticscholar   +1 more source